EUVIMEDEUVIMED entdecken
Leserbrief

Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

Metodi Balev iD, Victor Zibara, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya, Michelle Becker, Alla Keyzner, Alan H Shih, Bridget Marcellino, Hannah Levavi, Lewis Silverman, John Mascarenhas und 1 weitere

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27429 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Metodi Balev und 12 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multivariable analysis for overall survival and relapse-free survival demonstrating lack of significant for D14 BM status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHumansFemaleMaleMiddle AgedDisease-Free SurvivalAgedAdultBone MarrowBiopsyAdolescentRisk AssessmentAged, 80 and overPrognosis

Autor:innen und Institutionen

  • Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York, USA.

ORCID-Profile: Metodi Balev

Zitieren

APA

Balev, M., Zibara, V., Van Hyfte, G., Feld, J., Kremyanskaya, M., Becker, M., Keyzner, A., Shih, A. H., Marcellino, B., Levavi, H., Silverman, L., Mascarenhas, J., & Tremblay, D. (2024). Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27429

Vancouver

Balev M, Zibara V, Van Hyfte G, Feld J, Kremyanskaya M, Becker M, et al. Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia. American Journal of Hematology. 2024. doi:10.1002/ajh.27429

BibTeX
@article{Balev2024,
  author = {Balev, Metodi and Zibara, Victor and Van Hyfte, Grace and Feld, Jonathan and Kremyanskaya, Marina and Becker, Michelle and Keyzner, Alla and Shih, Alan H and Marcellino, Bridget and Levavi, Hannah and Silverman, Lewis and Mascarenhas, John and Tremblay, Douglas},
  title = {Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27429}
}
Kostenlos starten →